Childhood Rhabdomyosarcoma Treatment (PDQ®): Health Professional Version
- PMID: 26389243
- Bookshelf ID: NBK65802
Childhood Rhabdomyosarcoma Treatment (PDQ®): Health Professional Version
Excerpt
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of childhood rhabdomyosarcoma. It is intended as a resource to inform and assist clinicians in the care of their patients. It does not provide formal guidelines or recommendations for making health care decisions.
This summary is reviewed regularly and updated as necessary by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of the National Cancer Institute (NCI). The summary reflects an independent review of the literature and does not represent a policy statement of NCI or the National Institutes of Health (NIH).
Keywords: childhood rhabdomyosarcoma.
Sections
- General Information About Childhood Rhabdomyosarcoma
- Cellular Classification for Childhood Rhabdomyosarcoma
- Stage Information for Childhood Rhabdomyosarcoma
- Treatment Option Overview for Childhood Rhabdomyosarcoma
- Special Considerations for the Treatment of Children With Cancer
- Treatment of Childhood Rhabdomyosarcoma
- Treatment of Progressive or Recurrent Childhood Rhabdomyosarcoma
- Latest Updates to This Summary (04/11/2025)
- About This PDQ Summary
References
-
- National Cancer Institute: NCCR*Explorer: An interactive website for NCCR cancer statistics. Bethesda, MD: National Cancer Institute. Available online. Last accessed February 25, 2025.
-
- Surveillance Research Program, National Cancer Institute: SEER*Explorer: An interactive website for SEER cancer statistics. Bethesda, MD: National Cancer Institute. Available online. Last accessed December 30, 2024.
-
- WHO Classification of Tumours Editorial Board: WHO Classification of Tumours. Volume 3: Soft Tissue and Bone Tumours. 5th ed., IARC Press, 2020.
Publication types
LinkOut - more resources
Full Text Sources